公开(公告)号：US20210089893A1

公开(公告)日：2021-03-25

申请号：US16971917

申请日：2019-12-31

Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION ,  KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Ki Young CHOI ,  Jae Hyun KIM ,  Chae Un LEE ,  Joonyeon CHANG ,  Joon Young KWAK ,  Jaewook KIM

IPC: G06N3/08 ,  G06N3/04 ,  G06N3/063 ,  G06F17/18

Abstract: An embodiment of the present disclosure discloses a method of process variation compensating through activation value adjustment of an analog binarized neural network circuit that may recover a decrease in recognition rate performance up to an almost perfect level, even if a binarized neural network is implemented as an analog circuit such that recognition rate performance is decreased due to process variation.

公开(公告)号：US20250099390A1

公开(公告)日：2025-03-27

申请号：US18730898

申请日：2023-01-18

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Ki Young CHOI ,  Kwang-Hyun CHA ,  Hwa Seung HAN ,  Jin Soo PARK ,  Dae-geun SONG ,  Myung Suk KIM ,  Hak Cheol KWON

IPC: A61K9/50 ,  A61K35/74 ,  A61K35/745 ,  A61P37/06

Abstract: Provided is a method for preventing, ameliorating, or treating inflammatory diseases by administering a composition containing extracellular vesicles (EVs) derived from Roseburia spp. strains and/or Bifidobacterium spp. strains, wherein the EVs exhibits effectiveness in improving inflammatory bowel disease (IBD), and additionally, all EVs derived from congeneric strains corresponding to Roseburia spp. strains or Bifidobacterium spp. strains. have been confirmed to exhibit strong anti-inflammatory effect, and the strains and EVs derived therefrom can be provided as a composition for preventing, ameliorating, or treating a variety of inflammatory diseases.